|
O.M. Smirnova, I.V. Kononenko
Diabeton Mb In The Treatment Of Type 2 Diabetes Mellitus And Prevention Of Its Late Complications
|
№16 / 2011
|
|
N.A. Petunina, A.V. Brashcenkova
Saxagliptin (onglyza ®) In Conception Of Effective Management Of Type 2 Diabetes Mellitus
|
№16 / 2011
|
|
T.I. Severina, Ye.N. Popkova, N.Yu. Trelskaya, V.V. Yemelyanov
Clinical And Metabolic Efficiency Of Drug Dibikor In Patients With Type 2 Diabetes Mellitus
|
№5 / 2011
|
|
Glinkina I.V., Romancova T.I.
Results Of Observational Program On Use Of Insulin Glargine (lantus®) In Combination With Oral Hypoglycemic Agents For The Treatment Of Type 2 Diabetes Mellitus In Routine Clinical Practice
|
№3 / 2011
|
|
Anciferov M.B.
Clinical Aspects For Use Of Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Benefits For Different Groups Of Patients
|
№3 / 2011
|
|
Petunina N.A., Truhina L.V.
Combined Therapy Of Type 2 Diabetes Mellitus
|
№3 / 2011
|
|
Birukova E.V.
How To Achieve Effective Glycemic Control And Reduce The Risk Of Vascular Complications Due To Using Sulfonylurea Medications
|
№3 / 2011
|
|
Anciferov M.B.
Type 2 Diabetes Mellitus: Potentials For Achievement Of Optimal Control Without Side Effects
|
№3 / 2011
|
|
A.Yu Mayorov, Ye.V. Surkova, I.I. Dedov
Assessment Of Efficacy Of Education Of General Practitioners By The Training Program For Management Of Type 2 Diabetes Mellitus
|
№16 / 2010
|
|
O.V. Zanozina
Possibility Of Correction Of Oxidative Stress In Patients With Diabetes Using Dibicor
|
№16 / 2010
|
|
A.V. Rudakova
Pharmacoeconomic Aspects Of Use Of Sulfonylurea Medications In Insulin-independent Diabetes
|
№16 / 2010
|
|
M.B. Antsiferov, L.Yu. Morgunov, N.A. Demidov, I.V. Volokitin
Potentials For Use Of Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes Mellitus: Initiation And Continuation Of Therapy
|
№16 / 2010
|
Русский
